Speaker illustration

Ms Nuria Casamira

University Hospital Vall d'Hebron, Barcelona (Spain)

Use and outcomes of triple antithrombotic therapy with vitamin K antagonists versus non-vitamin K antagonists in patients with atrial fibrillation undergoing percutaneous coronary intervention

Event: ESC Congress 2017

Topic: PCI - Adjunctive drug therapy

Session: PCI - Adjunctive drug therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb